Candriam SCA’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-130,547
| Closed | -$14.5M | – | 952 |
|
|
2021
Q1 | $14.5M | Hold |
130,547
| – | – | 0.12% | 188 |
|
|
2020
Q4 | $15.1M | Buy |
130,547
+22,120
| +20% | +$2.48M | 0.12% | 190 |
|
|
2020
Q3 | $10.6M | Sell |
108,427
-11,535
| -10% | -$1.33M | 0.1% | 220 |
|
|
2020
Q2 | $14.7M | Buy |
119,962
+44,151
| +58% | +$5.01M | 0.16% | 163 |
|
|
2020
Q1 | $7.75M | Hold |
75,811
| – | – | 0.09% | 262 |
|
|
2019
Q4 | $7.93M | Buy |
75,811
+24,611
| +48% | +$2.76M | 0.09% | 266 |
|
|
2019
Q3 | $5.89M | Hold |
51,200
| – | – | 0.08% | 284 |
|
|
2019
Q2 | $8.79M | Buy |
51,200
+10,000
| +24% | +$1.73M | 0.11% | 208 |
|
|
2019
Q1 | $6.95M | Hold |
41,200
| – | – | 0.09% | 256 |
|
|
2018
Q4 | $4.01M | Buy |
41,200
+4,580
| +13% | +$601K | 0.06% | 323 |
|
|
2018
Q3 | $6.33M | Buy |
36,620
+10,700
| +41% | +$1.54M | 0.08% | 274 |
|
|
2018
Q2 | $3.62M | Buy |
25,920
+2,500
| +11% | +$355K | 0.06% | 360 |
|
|
2018
Q1 | $2.64M | Buy |
23,420
+420
| +2% | +$52.8K | 0.05% | 416 |
|
|
2017
Q4 | $3.04M | Sell |
23,000
-6,000
| -21% | -$705K | 0.05% | 376 |
|
|
2017
Q3 | $2.94M | Buy |
29,000
+5,000
| +21% | +$535K | 0.05% | 374 |
|
|
2017
Q2 | $2.41M | Buy |
24,000
+7,000
| +41% | +$753K | 0.05% | 429 |
|
|
2017
Q1 | $2.06M | Buy |
17,000
+3,000
| +21% | +$368K | 0.04% | 438 |
|
|
2016
Q4 | $1.56M | Buy |
14,000
+3,000
| +27% | +$361K | 0.04% | 416 |
|
|
2016
Q3 | $1.46M | Sell |
11,000
-5,000
| -31% | -$478K | 0.04% | 421 |
|
|
2016
Q2 | $1.47M | Buy |
+16,000
| New | +$1.35M | 0.04% | 363 |
|
Other funds holding GWPH
Candriam SCA's GWPH Position: Q2 2021 in Review
Candriam SCA sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 130,547 shares — an estimated $14.5M sold.
Candriam SCA first reported a position in GWPH in Q2 2016 and held it in 20 quarters. The position peaked at $15.1M in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Candriam SCA reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Candriam SCA sold 130,547 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $14.5M.
- Candriam SCA first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 20 quarters.
- Candriam SCA's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15.1M in Q4 2020.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.